1 Min Read
April 4 (Reuters) - Biophytis Sa-
* Biophytis secures funding for phase 2b clinical trial in sarcopenia, sara-interest Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.